Why is MOLN.SW stock falling today?

MOLN.SW stock is down intraday due to thin volume, sector-wide biotech weakness, and profit-taking after recent gains. Traders are testing support at CHF 3.15 while awaiting pipeline news and the next earnings window on 12 May 2026.

What are the main valuation metrics for MOLN.SW stock?

Key metrics: market cap CHF 117,807,329.00, EPS -1.65, PE -1.91, price-to-book 1.47, cash per share CHF 2.49, and current ratio 8.79. These show a cash-rich balance sheet but persistent operating losses.

What does Meyka AI forecast for MOLN.SW stock?

Meyka AI's forecast model projects a yearly price of CHF 2.35 for MOLN.SW stock, implying roughly -28.37% versus the current CHF 3.28. Forecasts are model-based and not guarantees; monitor pipeline catalysts and liquidity.

Should I trade MOLN.SW stock before earnings?

Trading before earnings is higher risk due to potential headline-driven swings. MOLN.SW stock has low average volume and high news sensitivity; use tight risk controls and watch support at CHF 3.15 and the 200-day average CHF 3.17.

CH Stocks

MOLN.SW Molecular Partners AG (SIX) -1.20% to CHF3.28 on 18 Mar 2026: CHF3.15 key

ByHuzaifa Zahoor March 18, 2026March 18, 2026

MOLN.SW stock is the intraday top loser on SIX, down 1.20% to CHF 3.28 on 18 Mar 2026 as traders test short-term support. Volume is light at 3,562.00 shares versus a 50-day average of 22,191.00, keeping moves volatile. The stock opened at CHF 3.15 and traded a session low at CHF 3.15 and a high at CHF 3.28. We track valuation, technicals and upcoming catalysts to explain why Molecular Partners AG is under pressure and what to watch next.